WAYL.CN - Wayland Group Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.9000
-0.0300 (-3.23%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.9300
Open0.9400
Bid0.9000 x 0
Ask0.9100 x 0
Day's Range0.8800 - 0.9400
52 Week Range0.7800 - 2.1500
Volume1,617,128
Avg. Volume743,034
Market Cap207.566M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3530
Earnings DateMay 1, 2019 - May 6, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire15 hours ago

    Wayland Group Announces Anticipated Delay in Annual Filings

    Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it anticipates a delay in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”) with Canadian securities regulators until after the April 30, 2019 filing deadline. The additional time is required to permit the Company’s auditors, MNP LLP, to complete its review and enquiries in connection with the audit of the Company’s 2018 financial statements. The Company and its auditors are working diligently, and the Company intends to make the Required Filings as soon as possible and it expects to make these filings by no later than June 14, 2019.

  • GlobeNewswire15 hours ago

    REPEAT - Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (8K51.F) (WLDCF) (“ICC”). The terms of the definitive agreement are consistent with the Letter of Intent that was announced on January 15, 2019.  Wayland will receive 300,000,000 shares of ICC under the agreement, representing approximately 35% of the current outstanding ICC shares on a fully diluted basis. Wayland is also pleased to announce that Matthew McLeod, the current General Counsel and Vice President Operations and Compliance, has been appointed as President effective immediately.

  • GlobeNewswire15 hours ago

    REPEAT - International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group

    ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international asset and license portfolio. Under the terms of the definitive agreement, International Cannabis will issue Wayland 300,000,000 shares in the capital of ICC, representing approximately 38% of the current outstanding ICC shares on a fully diluted basis.

  • GlobeNewswire23 hours ago

    Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (8K51.F) (WLDCF) (“ICC”). The terms of the definitive agreement are consistent with the Letter of Intent that was announced on January 15, 2019.  Wayland will receive 300,000,000 shares of ICC under the agreement, representing approximately 35% of the current outstanding ICC shares on a fully diluted basis. Wayland is also pleased to announce that Matthew McLeod, the current General Counsel and Vice President Operations and Compliance, has been appointed as President effective immediately.

  • GlobeNewswire23 hours ago

    International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group

    ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international asset and license portfolio. Under the terms of the definitive agreement, International Cannabis will issue Wayland 300,000,000 shares in the capital of ICC, representing approximately 38% of the current outstanding ICC shares on a fully diluted basis.

  • GlobeNewswire5 days ago

    Wayland Provides Clarification on Recent German Tender Update

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) would like to expand on the update that the Company provided to the market on April 17, 2019 with respect to the ongoing process for domestic cultivation of medical cannabis in Germany (“the Update”). The Company would like to clarify that Wayland’s joint venture with DEMECAN GmbH (“DEMECAN”) received a score of 60/60 for quality and 40/40 for pricing in the original tender process from early in 2018. Notwithstanding the challenge to the most current tenders described in the Update, the Company is confident that DEMECAN will be successful, and will be awarded the 3 lots for production.

  • GlobeNewswire6 days ago

    Wayland Provides Update on German Tender Process

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Wayland, through its joint venture with DEMECAN GmbH (“DEMECAN”), was originally selected by BfArM to receive three licenses to produce medical cannabis in Germany. Wayland’s quality concept received 60 out of 60 points for quality and 40 out of 40 points for price.

  • GlobeNewswire11 days ago

    Wayland Group Announces Facility Drawdown

    TORONTO, April 12, 2019 -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the fifth.

  • GlobeNewswire14 days ago

    Wayland Group Announces Changes to the Board of Directors

    Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announces the following change to its Board of Directors. Due to personal reasons, Rudi Hilti has resigned as Director of Wayland Group Corp. Mr. Hilti’s responsibilities at his own commercial and non-commercial enterprises have increased to a level that would compromise his time and effectiveness as a board member of the Company. Wayland would like to thank Rudi for his contributions to the Company and wishes him well in his future endeavors.

  • CNW Group19 days ago

    IIROC Trade Resumption - WAYL

    IIROC Trade Resumption - WAYL

  • GlobeNewswire19 days ago

    Wayland Selected as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is excited to announce that the Company has been selected by the German Federal Institute for Drugs and Medical Devices (“BfArM”), through its German joint venture DEMECAN GmbH, to begin domestic production of medical cannabis for the rapidly growing German patient population. The Company is one of three groups that have been selected and is subject to a review period, after which a final decision will be made no earlier than April 17, 2019. From the beginning, the market opportunity for medical cannabis in Germany has been a key part of Wayland’s global growth strategy.

  • CNW Group19 days ago

    IIROC Trading Halt - WAYL

    IIROC Trading Halt - WAYL

  • GlobeNewswirelast month

    REPEAT - International Cannabis and Wayland Confirm Intent to Finalize Transaction

    VANCOUVER, British Columbia, March 11, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) ("ICC" or “International Cannabis” or the “Company”) is.

  • GlobeNewswirelast month

    International Cannabis and Wayland Confirm Intent to Finalize Transaction

    VANCOUVER, British Columbia, March 11, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) ("ICC" or “International Cannabis” or the “Company”) is.

  • GlobeNewswire2 months ago

    Wayland Group Provides Corporate Update

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce a corporate update on its operational progress in Canada and internationally. The Company is now completing a third harvest at its new facility in Langton, ON, Canada, with licenses for cultivation and business to business sales received in April 2018 and December 2018 respectively. The Company, in partnership with Industrial Automation Solutions (IAS New York Inc.), of Rochester NY, and their partner Rockwell Automation, have completed a proof of concept (“POC”) for both the facility and automation platform.

  • GlobeNewswire2 months ago

    International Cannabis Applauds Receipt of EU-GMP Certification for German Ebersbach Facility 

    VANCOUVER, British Columbia, Feb. 08, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: KNHBF) ("ICC" or “International Cannabis” or the “Company”).

  • GlobeNewswire2 months ago

    REPEAT - Wayland Group Receives EU-GMP Certification for German Facility

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that it has received both Good Manufacturing Practices and Good Distribution Practices certifications from the national authority in the State of Saxony for the Company’s Ebersbach facility in Germany. Specifically, these certifications are for a 50,000 square foot area within Wayland’s much larger facility located just outside of Dresden, Germany. This marks Wayland’s second facility to receive the EU-GMP certification, the highest standard of pharmaceutical production in the world.

  • GlobeNewswire2 months ago

    Wayland Group Receives EU-GMP Certification for German Facility

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that it has received both Good Manufacturing Practices and Good Distribution Practices certifications from the national authority in the State of Saxony for the Company’s Ebersbach facility in Germany. Specifically, these certifications are for a 50,000 square foot area within Wayland’s much larger facility located just outside of Dresden, Germany. This marks Wayland’s second facility to receive the EU-GMP certification, the highest standard of pharmaceutical production in the world.

  • GlobeNewswire3 months ago

    Wayland Group Comments on Recent Promotional Market Activity

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company) wishes to make the following statements regarding recent market activity in its common shares traded on the OTCQB marketplace. The Company has been asked to issue this release by OTC Markets to comment on certain continued promotional activities beginning on or around January 29, 2019. The Company became aware of certain continued promotional activity relating to its securities on January 30, 2019 upon receipt of correspondence from OTC Markets specifically related to certain promotional literature encouraging investors to purchase the Company's common shares and making certain statements regarding the potential returns on such investment, including certain promotional newsletter emails.

  • GlobeNewswire3 months ago

    REPEAT - International Cannabis and Wayland to Begin Integration of European Extraction and Distillation Processes; to Process 125,000 kg of CBD Flower  

    ICC International Cannabis Corp. (CSE:WRLD.U) (8K51.F) (WLDCF) ("ICC" or “International Cannabis” or the “Company”) is pleased to announce that further to the signed Letter of Intent (“LOI”) with Wayland Group Corp. (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) (see ICC news release dated January 15, 2019), the companies will begin integration of its extraction and distillation processes, in addition to finished dose manufacturing of CBD products for the European market.

  • GlobeNewswire3 months ago

    International Cannabis and Wayland to Begin Integration of European Extraction and Distillation Processes; to Process 125,000 kg of CBD Flower  

    ICC International Cannabis Corp. (CSE:WRLD.U) (8K51.F) (WLDCF) ("ICC" or “International Cannabis” or the “Company”) is pleased to announce that further to the signed Letter of Intent (“LOI”) with Wayland Group Corp. (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) (see ICC news release dated January 15, 2019), the companies will begin integration of its extraction and distillation processes, in addition to finished dose manufacturing of CBD products for the European market.